TP53 and neoplasm: Considering that mutant p53 contributes to the acquisition and/or maintenance of drug-resistant phenotype of certain malignant tumor cells [9–11], we asked whether forced depletion of mutant p53 could enhance SAHA sensitivity of MiaPaCa-2 cells.